The class of chemicals listed as IFT43 Activators includes various compounds that indirectly influence IFT43 through their effects on ciliary assembly, microtubule dynamics, and related cellular processes. These compounds are not direct activators of IFT43 but may impact its function by modulating the cellular environment and mechanisms involved in ciliogenesis and intraflagellar transport.Microtubule-targeting agents such as Paclitaxel, Nocodazole, Colchicine, and Vincristine play critical roles in influencing microtubule dynamics, which are essential for the assembly and maintenance of cilia. Alterations in microtubule stability or organization can indirectly affect the function of IFT43 in ciliary assembly.Compounds that disrupt actin dynamics (Cytochalasin D) or Golgi apparatus function (Brefeldin A) may also have indirect effects on IFT43, considering the importance of cytoskeletal and trafficking processes in ciliogenesis.
Agents that modulate cellular signaling pathways involved in ciliary development, such as Forskolin (increasing cAMP), Lithium Chloride (inhibiting GSK-3), Rapamycin, and AZD8055 (mTOR inhibitors), might indirectly impact IFT43 function by influencing pathways relevant to cilia formation and function.Chloroquine, by affecting endosomal trafficking, and MG-132, a proteasome inhibitor, could also indirectly influence IFT43 by modulating the cellular environment and pathways critical for the maintenance of ciliary components.Overall, while these compounds do not specifically target IFT43, their roles in key processes related to ciliogenesis and intraflagellar transport suggest they could have an indirect impact on the functionality of IFT43 in ciliary assembly and maintenance
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel, a microtubule stabilizer, may indirectly affect IFT43 by influencing microtubule dynamics, which are crucial for cilia formation and function. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole, a microtubule-depolymerizing agent, could indirectly impact IFT43 function by altering microtubule dynamics involved in ciliary assembly. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Colchicine, which disrupts microtubule polymerization, might indirectly influence IFT43 function in cilia. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D, an actin filament disrupting agent, could have an indirect impact on IFT43 by affecting cytoskeletal dynamics related to ciliary function. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, known to increase cAMP levels, might influence IFT43 indirectly through pathways affecting ciliogenesis. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride, a GSK-3 inhibitor, may indirectly impact IFT43 function by influencing pathways involved in ciliary development. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A, which disrupts Golgi apparatus function, could affect IFT43 indirectly by impacting ciliary protein trafficking. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine, known to affect endosomal trafficking, might indirectly influence IFT43 function in ciliary assembly and maintenance. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132, a proteasome inhibitor, could impact IFT43 indirectly by affecting protein degradation pathways related to ciliary components. | ||||||
AZD8055 | 1009298-09-2 | sc-364424 sc-364424A | 10 mg 50 mg | $163.00 $352.00 | 12 | |
AZD8055, another mTOR inhibitor, might influence IFT43 function indirectly by modulating signaling pathways involved in ciliogenesis. | ||||||